PDB 6g5k
PDB Information
PDB | 6G5K |
Method | X-RAY DIFFRACTION |
Host Organism | Escherichia coli BL21(DE3) |
Gene Source | Clostridium botulinum |
Primary Citation | Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.
Sci Adv
|
Header | Toxin |
Released | 2018-03-29 |
Resolution | 2.000 |
CATH Insert Date | 20 Jan, 2019 |
PDB Images (9)
PDB Prints
PDB Chains (4)
Chain ID | Date inserted into CATH | CATH Status |
---|---|---|
A | 20 Jan, 2019 | Chopped |
B | 20 Jan, 2019 | Chopped |
C | 20 Jan, 2019 | Rejected |
D | 20 Jan, 2019 | Rejected |
CATH Domains (4)
Domain ID | Date inserted into CATH | Superfamily | CATH Status |
---|---|---|---|
6g5kA01 | 21 Jan, 2019 | 2.60.120.200 | Assigned |
6g5kA02 | 21 Jan, 2019 | 2.80.10.50 | Assigned |
6g5kB01 | 21 Jan, 2019 | 2.60.120.200 | Assigned |
6g5kB02 | 21 Jan, 2019 | 2.80.10.50 | Assigned |
UniProtKB Entries (4)
Accession | Gene ID | Taxon | Description |
---|---|---|---|
P10844 | BXB_CLOBO | Clostridium botulinum | Botulinum neurotoxin type B |
P10844 | BXB_CLOBO | Clostridium botulinum | Botulinum neurotoxin type B |
P21579 | SYT1_HUMAN | Homo sapiens | Synaptotagmin-1 |
P21579 | SYT1_HUMAN | Homo sapiens | Synaptotagmin-1 |